New York Life Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,099
Closed -$299K 230
2015
Q3
$299K Hold
1,099
0.03% 171
2015
Q2
$334K Sell
1,099
-630
-36% -$188K 0.04% 150
2015
Q1
$515K Buy
1,729
+780
+82% +$222K 0.06% 79
2014
Q4
$244K Buy
+949
New +$237K 0.03% 173
2014
Q1
Sell
-1,500
Closed -$252K 183
2013
Q4
$252K Sell
1,500
-200
-12% -$31.3K 0.06% 61
2013
Q3
$245K Sell
1,700
-100
-6% -$13.3K 0.08% 63
2013
Q2
$227K Buy
+1,800
New +$204K 0.07% 59

Other funds holding AGN

New York Life Investment Management's AGN Position: Q4 2015 in Review

New York Life Investment Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 1,099 shares — an estimated $299K sold.

New York Life Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $515K in Q1 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • New York Life Investment Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • New York Life Investment Management sold 1,099 Allergan plc shares in Q4 2015, an estimated $299K.
  • New York Life Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • New York Life Investment Management's Allergan plc position peaked at $515K in Q1 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on New York Life Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.